UllCORE BSI Test for Bloodstream Infections
Official title: Evaluation of Diagnostic Accuracy and Clinical Performance of the UllCORE Bloodstream Infection (BSI) Test
Run by Deepull Diagnostics S.L. · NCT07859852 · Data updated 2026-11-12
This study tests whether the UllCORE BSI Test can correctly detect bloodstream infection pathogens and resistance markers from whole blood in people with suspected infection or sepsis.
Quick facts
| Study type | Observational |
|---|---|
| Sex | All |
| Enrollment | 1500 (estimated) |
| Sponsor | Deepull Diagnostics S.L. Industry-sponsored |
| Locations | 20 sites (Orange, California and 19 other locations) |
| Status | Recruiting |
| Started | September 21, 2026 |
| Main results expected | April 2027 |
| Study ends | October 2027 |
| Registry record updated | October 8, 2026 |
| Trial ID | NCT07859852 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults and children with signs of suspected bloodstream infection or sepsis who can provide consent and have two EDTA blood tubes collected alongside standard-of-care cultures.
✕Probably not a fit
Patients whose bloodstream infection is not detectable by the UllCORE BSI Test or whose infection does not require detection of the tested resistance markers may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study compares the UllCORE BSI Test results from whole blood with standard blood culture results in patients with suspected bloodstream infection or sepsis. Samples are collected at the same time as routine blood cultures and tested either fresh or after freezing, following a predefined protocol. The goal is to characterize the diagnostic performance of the investigational test without using its results to guide patient care. Data from multiple sites, including UC Irvine Medical Center, Tampa General Hospital, and Johns Hopkins Hospital, will support sensitivity, specificity, and concordance analyses against conventional microbiology methods. No clinical decisions will be made based on UllCORE BSI Test results for this study.
Why it matters
Potential benefit: If successful, the UllCORE BSI Test could improve rapid detection of bloodstream pathogens and resistance markers, potentially informing future patient care.
How similar studies have gone: Prior work in molecular diagnostics for bloodstream infections has shown promise, but this exact test in whole-blood samples is relatively novel and its clinical utility is still being established.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Any age (where the remaining criteria can be safely fulfilled) * Ability to provide consent/assent in accordance with Institutional Review Board (IRB)/Ethics Committee (EC) determinations * The patient is presenting with signs and symptoms of suspected bloodstream infection (BSI) or fulfils the criteria for the hospital sepsis protocol. Planned blood culture collection and laboratory analysis as per standard of care (SOC). • Patient is able and an appropriate candidate to be able to collect 2 K2 ethylenediaminetetraacetic acid (EDTA) tubes of whole blood. Exclusion Criteria: * Unable to collect UllCORE BSI Test samples from the same venipuncture as blood culture (BC) samples * Patient was previously enrolled in the study
Where it's running
-
University Hospitals Cleveland Medical Center
Cleveland, Ohio, United States Recruiting -
University of California at Irvine Medical Center
Orange, California, United States Not yet recruiting -
Tampa General Hospital
Tampa, Florida, United States Not yet recruiting -
The Johns Hopkins Hospital
Baltimore, Maryland, United States Not yet recruiting -
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States Not yet recruiting -
Henry Ford Health
Novi, Michigan, United States Not yet recruiting
Show 14 more locations
-
Washington University School of Medicine
St Louis, Missouri, United States Not yet recruiting -
Geisinger Health
Danville, Pennsylvania, United States Not yet recruiting -
Vanderbilt health
Nashville, Tennessee, United States Not yet recruiting -
Baylor Scott & White Health Medical Center-Temple
Temple, Texas, United States Not yet recruiting -
CHU de Limoges - Hôpital Dupuytren
Limoges, France Not yet recruiting -
Hôpital de la Croix-Rousse - HCL
Lyon, France Not yet recruiting -
Charité - Campus Benjamin Franklin
Berlin-Zehlendorf, Germany Not yet recruiting -
Universitaetsklinikum Jena
Jena, Germany Not yet recruiting -
Universitaetsklinikum Leipzig
Leipzig, Germany Not yet recruiting -
Azienda Ospedaliera Universitaria Careggi
Florence, Italy Not yet recruiting -
Ospedale di Perugia Santa Maria della Misericordia
Perugia, Italy Not yet recruiting -
Hospital Germans Trias I Pujol
Badalona, Spain Not yet recruiting -
Hospital Universitari Vall d'Hebron - VHIO
Barcelona, Spain Not yet recruiting -
Hospital Clínic de Barcelona
Barcelona, Spain Not yet recruiting
Study contacts
- Study coordinator: Roger Canton
- Email: rcanton@deepull.com
- Phone: 936553530
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
New care guideline for infants 60 days and younger with fever in Sweden
This project will test a new guideline to see if infants 60 days or younger with fever can safely avoid many invasive tests, hospital stays, and broad antibiotics compared with usual care.
-
Improving vancomycin dosing for young infants with infections
This study is testing a new way to give the right amount of vancomycin to young infants with infections to help them get better faster.
-
Using fosfomycin to treat severely infected patients
This study is testing if an intravenous antibiotic called fosfomycin can safely help people with serious infections like osteomyelitis and bacterial meningitis feel better.
-
Pneumococcal infection surveillance in Lebanon
This study is trying to find out which types of bacteria cause serious infections like pneumonia in Lebanon and how well current vaccines and antibiotics work against them.
-
Ruta C and Vitamin C in Sepsis: Adding antioxidants to standard care
This trial tests whether adding Ruta C (rutin plus vitamin C) or vitamin C alone to standard sepsis treatment helps adults in the ICU stay shorter and recover better.
-
Early detection of sepsis-related blood clotting problems in severe burn patients
This study tests how well the JAAM-2 score can detect sepsis-induced coagulopathy early in adults with severe burns who develop sepsis in the ICU.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.